Oxytocin Ban: Case to have far-reaching effects on Public Health Rights, SC refers matter to larger Bench

Meera Emmanuel August 25 2019
social media

Can private companies produce the Oxytocin drug for domestic use in India?

On Thursday, a Division Bench of the Supreme Court held that the question raises serious issues having far-reaching implications and referred it to a three-judge Bench. The order passed by a Bench of Justices AM Sapre and Indu Malhotra states,

"... this is a fit case to refer the matter to a larger Bench of three Judges to consider the aforesaid . . .

This content is restricted to subscribers